Background {#Sec1}
==========

Traditional medicines have been used for prevention and treatment of diseases for thousands of years in China. In recent decades, they have attracted worldwide attention due to their reliable therapeutic efficacy and low side effects. During the long-term struggle against diseases, ancient Chinese doctors found that some unexpected materials, such as human or animal feces, could also effectively treat diseases. In China, the medical use of fecal matter (fresh fecal suspension or dry feces) has a long history. During the Eastern Jin dynasty ([ad]{.smallcaps} 300--400 years), "*Zhou Hou Bei Ji Fang*", a well-known monograph of traditional Chinese medicine (TCM) written by Hong Ge, recorded a case of treating patients with food poisoning or severe diarrhea by ingesting human fecal suspension (known as yellow soup or Huang-Long decoction) \[[@CR1]\]. During the Tang dynasty, Yutuo Ningma Yundan Gongbu compiled a world-famous book of Tibetan medicine called "*The Four Medical Tantras*", which recorded that digestive diseases can be treated with the processed product of the feces of *Sus scrofa* (Hei-Bing-Pian in Chinese) \[[@CR2]\]. Later, the "*Compendium of Materia Medica*" (a masterpiece of herbalism written by Shizhen Li during the Ming dynasty) described a series of prescriptions for treating diarrhea, rheumatism, jaundice, fever, and pain using fresh fecal suspension or dry feces \[[@CR3]\]. In addition, "*Jing Zhu Materia Medica*" written by Danzeng Pengcuo Dimaer in the nineteenth century recorded that Hei-Bing-Pian and the dry feces of *Gypaetus barbatus* or *Aegypius monachus* (Jiu-Fen in Chinese) are commonly used to treat dyspepsia and gastric ulcer \[[@CR4]\]. These records indicate that fecal medicines are widely used and occupy an important position in Chinese traditional medical systems.

In long-term clinical practice, Chinese doctors have accumulated unique experience in the use of fecal medicines. For example, the dry feces of *Trogopterus xanthipes* (Wu-Ling-Zhi in Chinese) is often used to treat blood stasis, swelling and aching due to traumatic injury \[[@CR5]\]. Jiu-Fen is good at treating gastrointestinal diseases, such as dyspepsia, weak gastrointestinal function and gastric ulcer. Hei-Bing-Pian can treat diseases, such as indigestion, diarrhea and distending pain in the stomach \[[@CR6]\]. These traditional medication experiences are undoubtedly valuable assets and can provide a reference for modern drug development. However, documents on the traditional use of fecal medicines are scattered and lack systematic collation.

In this review, we comprehensively collect and summarize the names, origins, and treated diseases of fecal medicines that have been used in some Chinese traditional medical systems, including TCM, Tibetan ethnic medicine (EM), Oroqen EM, Kazak EM, Uygur EM, Mongolian EM, Nu EM, Yao EM, Wa EM, Tujia EM, Korean EM, Jino EM, Hani EM, and Dai EM. In addition, we review the most frequently used fecal medicines in terms of their origins, traditional uses, chemical constituents, and pharmacological activities. Such information can provide a good reference for their development and utilization. These fecal medicines may be a valuable gift from Chinese traditional medicine to the world and has potential as drug candidates for the treatment of some chronic diseases, such as gastrointestinal diseases.

Methods {#Sec2}
=======

We have manually searched 31 related medicine monographs and drug standards, such as "*Zhou Hou Bei Ji Fang*", "*Compendium of Materia Medica*", "*Jing Zhu Materia Medica*", "*Dictionary of Chinese Ethnic Medicine*", "*Drug Standards of Tibetan Medicine*", "*Lan Liu Li*", "*Pharmacopoeia of the People's Republic of China"*, and "*Chinese Tibetan Materia Medica*", to obtain the information about the names, origins, traditional uses, and treated diseases of fecal medicines. In addition, we have searched the online Chinese literature databases (i.e., Wan fang and CNKI) and international English databases (i.e., PubMed, ISI Web of Science and Google Scholar), using their vernacular or Latin names as keywords, to obtain their chemical constituents and biological effects.

Results {#Sec3}
=======

This review recorded 54 fecal medicines that have been used in 14 Chinese traditional medical systems. Their names, original species, medicinal forms, and treated diseases are presented in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. These 54 medicines mainly originate from the feces of 56 animals. Among medicinal forms used, dry feces is the most frequently used (66.67%), followed by processed feces (29.63%) and fresh fecal juice (3.70%). In addition, we found that these 54 fecal medicines are mainly used to treat gastrointestinal (37.04%), nervous system (22.22%), skin (22.22%), ophthalmic (18.52%), and gynecological diseases (16.67%).Table 1Fecal medicines used in the traditional Chinese medicine (TCM) systemNo.Animal speciesMedicinal formChinese nameTraditional uses (treated diseases)Refs.1*Trogopterus xanthipes* Milne-EdwardsDry fecesWu-Ling-ZhiStabbing pain in chest and abdomen, dysmenorrhea, amenorrhea, swelling and aching due to traumatic injury, and snake bites\[[@CR5], [@CR8], [@CR52]\]2*Bombyx mori* L.Dry fecesCan-ShaRheumatism, arthralgia, skin numbness, cold pain in waist and legs, rubella itching, and headache\[[@CR3], [@CR52]\]3*Vespertilio superans* ThomasDry fecesYe-Ming-ShaNight blindness, swelling and pain in the eyes, infantile malnutrition, scrofula, and malaria\[[@CR5], [@CR53]\]*Rhinolophus ferrumequinum* Schreber*Plecotus auritus* L.*Hipposideros armiger* Hodgson4*Lepus mandschuricus* RaddeDry fecesWang-Yue-ShaBlurred vision, hemorrhoids and fistula, and infantile malnutrition\[[@CR52], [@CR54], [@CR55]\]*Lepus sinensis* Gray*Lepus oiostolus* Hodgson5*Gallus gallus domesticus* BrissonDry fecesJi-Shi-BaiJaundice, gonorrhea, wandering arthritis, tetanus, spasm of muscles and tendons, and diabetes\[[@CR3], [@CR56]\]6*Rattus flavipectus* Milne-EdwardsDry fecesLiang-Tou-JianFever due to typhoid, abdominal pain, stranguria with turbid urine, amenorrhea, infantile malnutrition, mammary abscess, and furuncle\[[@CR56]--[@CR58]\]*Rattus norvegicus* Berkenhout7*Columba livia domestica* L.Dry fecesZuo-Pan-LongAbdominal mass, scrofula and tetanus\[[@CR3], [@CR57]\]8*Physeter macrocephalus* L.Dry fecesLong-Xian-XiangComa due to stuffiness, abdominal pain, cough and dyspnea, and gonorrhea\[[@CR52], [@CR56]\]9*Passer montanus* L.Dry fecesBai-Ding-XiangAbdominal mass, carbuncle and furuncle, blurred vision, pterygium, and dental caries\[[@CR55], [@CR56], [@CR58]\]10Homo sapiensFresh fecal juiceYellow soup or Huang-Long decoctionFood poisoning, severe diarrhea, heat toxin, and unconsciousness due to high fever\[[@CR1], [@CR3]\]11*Hirundo daurica* L.Dry fecesYan-Zi-FenEdema, malaria, insect poison, ulcer and sore\[[@CR3], [@CR56]\]12*Pavo muticus* L.Dry fecesKong-Que-FenExcessive leucorrhea in women, dysuria and furuncle\[[@CR3], [@CR56]\]13*Bos taurus domesticus* GmelinFresh fecal juice or dry fecesNiu-FenFresh fecal juice can cure jaundice caused by diabetes, beriberi, cholera, and dysuria; dry feces can treat malignant sore, cervical lymph node and tuberculosis fistula\[[@CR3], [@CR56]\]*Bubalus bubalis* L.14*Ochotona thibetana* Milne-EdwardsDry fecesCao-Ling-ZhiIrregular menstruation, stagnant abdominal pain, stomach pain, traumatic injury, and blood stasis\[[@CR56], [@CR57]\]*Ochotona erythrotis* Buchner Table 2Fecal medicines used in other traditional ethnic medicine (EM) systems in ChinaNo.Animal speciesMedicinal formTraditional medical systemsTraditional uses (treated diseases)Refs.1*Gypaetus barbatus* L.Dry fecesTibetan EM and mongolian EMDyspepsia, abdominal distension, intestinal tumor, gastric ulcer, weak gastrointestinal function, sores and carbuncles\[[@CR2], [@CR4], [@CR6]\]*Aegypius monachus* L.2*Sus scrofa* L.Processed fecesTibetan EM and mongolian EMDyspepsia, biliary diseases, plague and distending pain of stomach\[[@CR6], [@CR36], [@CR59]\]3*Sus scrofa domestica* BrissonProcessed fecesTibetan EMDyspepsia, plague and biliary tumor\[[@CR4], [@CR36], [@CR60]\]4*Petaurista xanthotis* Milne-EdwardsDry fecesTibetan EMStomach pain, amenorrhea and dysmenorrhea\[[@CR59], [@CR60]\]5*Pteromys volans* L.Dry fecesOroqen EMDysentery and diarrhea\[[@CR60]\]Kazak EMMetrorrhagia, amenorrhea, and snake bites (external use)\[[@CR60]\]Uygur EMEczema, itching, amenorrhea, dysmenorrhea, stomach pain, and traumatic injury\[[@CR61]\]6*Riparia riparia* L.Processed fecesTibetan EMBloody dysentery, chronic diarrhea, women amenorrhea, and hematuria\[[@CR59], [@CR60]\]7*Felis ocreata domestica* BrissonProcessed fecesTibetan EMManic psychosis or madness\[[@CR36], [@CR60]\]8*Upupa epops* L.Processed fecesTibetan EMPsychopathy\[[@CR4], [@CR59]\]9*Vulpes vulpes* L.Dry fecesTibetan EMPsychopathy and epilepsy\[[@CR4], [@CR60]\]10*Trogopterus xanthipes* Milne-EdwardsDry fecesMongolian EMDiarrhea, gout and itching\[[@CR62]\]Nu EMCold, whooping cough and fever\[[@CR60]\]Tibetan EMStomach pain, dysmenorrhea and amenorrhea\[[@CR59], [@CR60]\]Tujia EMBlood stasis, furuncles, traumatic injury, dysmenorrhea, and snake bites (external use)\[[@CR60]\]Korean EMStabbing pain in chest and abdomen, dysmenorrhea, amenorrhea, swelling and aching due to traumatic injury\[[@CR60]\]Dai EMAmenorrhea, dysmenorrhea, pain due to blood stasis, and snake bites (external use)\[[@CR60]\]Yao EMDysmenorrhea, amenorrhea, and epilepsy\[[@CR63]\]11*Pipistrellus abramus* TemminckDry fecesWa EMAsthma, burn, night blindness, and infantile malnutrition\[[@CR60]\]Tibetan EMEpilepsy\[[@CR4], [@CR60]\]Tujia EMNight blindness, cataract, infantile malnutrition, and corneal nebula\[[@CR64]\]12*Vespertilio superans* ThomasDry fecesKorean EMNight blindness, intermittent fever, cataract, and underarm odor\[[@CR60]\]Yao EMNight blindness, corneal nebula, infantile malnutrition, and scrofula\[[@CR63]\]13*Plecotus kozlovi* BobrinskiProcessed fecesTibetan EMEye diseases, scrofula and infantile malnutrition\[[@CR60]\]14*Myotis mystacinus* KuhlProcessed fecesTibetan EMPsychosis and epilepsy\[[@CR60]\]15*Lepus capensis* L.Dry fecesTibetan EMBlurred vision, hemorrhoids and fistula, and infantile malnutrition\[[@CR4], [@CR59]\]16*Equus caballus orientalis* NoackProcessed fecesTibetan EMVarious parasitic diseases and vomiting\[[@CR65], [@CR66]\]17*Gallus gallus domesticus* BrissonDry fecesKorean EMJaundice, gonorrhea, tetanus, and diabetes\[[@CR60]\]Tibetan EMEye diseases\[[@CR4], [@CR60]\]Dai EMShoulder arthritis, tetanus and corneal scar\[[@CR60]\]18*Rattus rattus* L.Dry fecesTibetan EMEpilepsy\[[@CR59], [@CR60]\]19*Physeter macrocephalus* L.Dry fecesUygur EMNeurasthenia, memory loss and psychological impotence\[[@CR60]\]20*Passer montanus* L.Dry fecesJino EMManic psychosis or madness\[[@CR60]\]Hani EMHerniaTibetan EMSores and furuncles (external use)\[[@CR59], [@CR60]\]21*Columba rupestris* PallasDry fecesTibetan EMSwelling and suppuration\[[@CR2], [@CR60]\]22*Pavo muticus* L.Processed fecesTibetan EMInflammation\[[@CR4], [@CR36], [@CR59]\]23*Bos taurus domesticus* GmelinProcessed fecesTibetan EMFood poisoning, limbs pain, and spasm\[[@CR4], [@CR36], [@CR59]\]24*Canis lupus* L.Processed fecesTibetan EM and mongolian EMPsychopathy and swelling\[[@CR4], [@CR59]\]25*Tetraogallus tibetanus* GouldDry fecesTibetan EMVarious swelling\[[@CR2], [@CR36]\]26*Bubo bubo hemachalana* HumeProcessed fecesTibetan EMPsychopathy and epilepsy\[[@CR4], [@CR59], [@CR67]\]27*Pica pica* L.Dry fecesTibetan EMSkin diseases, such as sores and furuncles\[[@CR59], [@CR60]\]28*Streptopelia orientalis* LathamDry fecesUygur EMPurulent secretion of the ear; Pain caused by ear diseases\[[@CR61]\]29*Corvus corax* L.Processed fecesTibetan EMBromhidrosis, epilepsy, cough, and psychopathy\[[@CR59], [@CR60]\]30*Canis lupus familiaris* L.Processed fecesTibetan EMPsychopathy and swelling; Syphilis, psoriasis and anthracnose (external use)\[[@CR4], [@CR59], [@CR60]\]31*Elephas maximus* L.Dry fecesDai EMOphthalmitis\[[@CR60]\]32*Equus asinus* L.Processed fecesTibetan EMSores and furuncles (external use) and rabies\[[@CR4], [@CR59]\]33*Phalacrocorax carbo* L.Dry fecesKorean EMPigmented naevus (external use)\[[@CR60]\]34*Buteo hemilasius* Temminck et SchlegelDry fecesTibetan EMSores and furuncles (external use)\[[@CR4], [@CR59]\]35*Macaca mulatta* ZimmermannDry fecesTibetan EMInflammation, swelling and dysentery\[[@CR59], [@CR60]\]36*Ovis aries* L.Dry fecesTibetan EM"Huang-Shui" disease in arms and legs (external fumigation)\[[@CR59], [@CR60]\]37*Capra hircus* L.Dry fecesTibetan EMHeat toxin syndrome, nervous system diseases and leprosy\[[@CR4], [@CR60]\]Korean EMChild dysentery, borborygmus and convulsive epilepsy\[[@CR60]\]38*Tetrao urogalloides* MiddendorfDry fecesTibetan EMPsychopathy and swelling\[[@CR4]\]39*Lutra lutra* L.Processed fecesTibetan EMUterine diseases\[[@CR4], [@CR60]\]40*Moschus sifanicus* PrzewalskiDry fecesTibetan EMLimb numbness, paralysis and blood stasis\[[@CR4], [@CR36], [@CR59]\]

Fecal medicines used in the TCM system {#Sec4}
--------------------------------------

Traditional Chinese medicine is the most representative traditional medical system in China. It has a long history of more than 2500 years. In recent decades, TCM has attracted global attention due to its reliable therapeutic efficacy. Generally, TCM uses herbs, animals or minerals to treat diseases. In long-term clinical practices, animal feces have been found to be effective in treating some specific diseases under the guidance of TCM theory. As early as the Eastern Jin dynasty, human fecal juice (i.e., yellow soup) has been used by TCM practitioners to treat severe diarrhea \[[@CR1]\]. At present, some fecal medicines are still used in the clinical practice of TCM. In the 2015 edition *of Chinese Pharmacopoeia* \[[@CR7]\], 18 preparations have been found to contain fecal medicines (Table [5](#Tab5){ref-type="table"}). For example, "Shi-Xiang-Zhi-Tong Powder" and "Tong-Jing Pills" contain Wu-Ling-Zhi, and "Huang-Lian-Yang-Gan Pills" contains Ye-Ming-Sha (dry feces of some kinds of bats).

In the present study, a bibliographic investigation of TCM monographs and drug standards revealed 14 kinds of fecal medicines that are commonly used in the TCM system. They mainly come from the feces of 22 animals and are widely used to treat dysmenorrhea, amenorrhea, abdominal mass, diarrhea, and blurred vision. Additional information on these 14 medicines is provided in Table [1](#Tab1){ref-type="table"}. Wu-Ling-Zhi is the most representative fecal medicine in the TCM system (Fig. [1](#Fig1){ref-type="fig"}). Therefore, its traditional uses, chemical constituents and pharmacological activities are described in detail in the subsequent sections.Fig. 1The commonly used fecal medicines in traditional medical system of China (**a** Ye-Ming-Sha; **b** Wu-Ling-Zhi; **c** Can-Sha; **d** Jiu-Fen; **e** Hei-Bing-Pian)

### The dry feces of *Trogopterus xanthipes* (Wu-Ling-Zhi in Chinese) {#Sec5}

Wu-Ling-Zhi (Fig. [1](#Fig1){ref-type="fig"}b), also named as Goreishi or Trogopterorum faeces, is one of the commonly used fecal medicines. It derives from the dry feces of *Trogopterus xanthipes*. Wu-Ling-Zhi was first recorded in the classic Chinese medicinal book "*Kai Bao Ben Cao*" compiled in the Song Dynasty \[[@CR8]\]. Its traditional uses were described in several TCM monographs and drug standards. For example, "*Ben Cao Jing Shu*" recorded that Wu-Ling-Zhi had a good therapeutic effect on stabbing pain caused by blood stasis \[[@CR9]\]. In addition, the *Chinese Pharmacopoeia* 1990 edition recorded that Wu-Ling-Zhi had good effects of promoting blood circulation, removing blood stasis and relieving pain, and was usually used to treat the stabbing pain in the chest and hypochondrium, dysmenorrhea, amenorrhea, swelling and aching due to traumatic injury, postpartum blood stasis, and snake bites.

So far, some chemical constituents categorized as terpenoids, flavonoids, lignans, sterols, and esters have been isolated from Wu-ling-zhi. The chemical structures of representative compounds are shown in Fig. [2](#Fig2){ref-type="fig"}. Numata et al. \[[@CR10]\] found that the feces of *T. xanthipes* contain several cytotoxic triterpenes, namely, pomolic acid, 3-*O*-*cis*-*p*-coumaroyltormentic acid, 2α-hydroxyursolic acid, and jacoumaric acid. Subsequently, they isolated three new ursane-type triterpenes (i.e., goreishic acids I, II and III) from the feces of *T. xanthipes* in 1990 \[[@CR11]\]. In addition, 19 diterpenoids including three new isopimarane diterpenoids (trogopteroids A--C) and four new aromatic diterpenoids (trogopteroids D--G) were isolated from the feces of *T. xanthipes* \[[@CR12]\]. Yang et al. \[[@CR13]\] also isolated two new diterpenoids (wulingzhic acid A and wulingzhic acid B) from the feces of *T. xanthipes*. Additionally, the isolation and structural elucidation of flavonoids in Wu-Ling-Zhi were done by Yang et al. \[[@CR14]\]. Seven flavonoids such as kaempferol 3-*O*-α-[l]{.smallcaps}-(4″E-*p*-coumaroyl)-rhamnoside, hinokiflavone, afzelin, and quercitrin were found. In 2012, four new neolignans were obtained from the ethyl acetate fraction of methanol extract of Wu-Ling-Zhi \[[@CR15]\]. Subsequently, they also isolated neolignans that had been reported before from its methanolic extract and named trogopterins A--C \[[@CR16]\]. Moreover, Yang et al. \[[@CR17]\] isolated four new fatty acid esters from the feces of *T. xanthipes*. Currently, it was reported that dihydrositosterol, epifriedelanol, 5-methoxy-7-hydroxycoumarin, β-sitosterol, ursolic acid, protocatechuic acid, and daucosterol were also isolated from Wu-Ling-Zhi \[[@CR18], [@CR19]\]. Moreover, some volatile compounds identified by capillary gas chromatography combined mass spectrometry were also found in Wu-ling-zhi, such as dodecanoic acid, alpha-cedrol, tetradecanoic acid, and benzaldehyde \[[@CR20]\].Fig. 2Chemical structures of representative compounds isolated from Wu-Ling-Zhi and Hei-Bing-Pian

At present, there are some studies involving the quality control of Wu-Ling-Zhi. Yerigui et al. \[[@CR21]\] quantified five bile acids (i.e., cholic acid, deoxycholic acid, lithocholic acid, ursodeoxycholic acid, and taurocholic acid) in Wu-Ling-Zhi by using ultra high-performance liquid chromatography-mass spectrometry. Jiao et al. \[[@CR22]\] established a thin layer chromatography (TLC) method for qualitative identification of Wu-Ling-Zhi, and developed a high performance liquid chromatography (HPLC) method to simultaneously quantify three active ingredients (protocatechuic acid, hinokiflavone and amentoflavone) in Wu-Ling-Zhi. Recently, Chen et al. also established the quality standard of Wu-Ling-Zhi. They qualitatively and quantitatively analyzed quercetin, kaempferol and amentoflavone in Wu-Ling-Zhi by TLC and HPLC, respectively \[[@CR23]\]. These results can provide important reference for the quality control of Wu-Ling-Zhi.

Moreover, it is worth pointing out that extracts or chemical constituents obtained from the Wu-Ling-Zhi have been proved to possess a wide spectrum of pharmacological activities, such as anti-inflammatory, anti-cerebral ischemia, anti-gastric ulcer, and antithrombin effects. The basic pharmacological data of Wu-Ling-Zhi extracts and some isolated compounds are shown in Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}. Kim et al. \[[@CR24]\] reported that Wu-Ling-Zhi extract could reduce lipopolysaccharide-induced NO and cytokines production. Wang et al. \[[@CR25]\] found that the ethyl acetate extract of Wu-Ling-Zhi showed obvious inhibitory effects on xylene-induced ear swelling in mice and carrageenan-induced paw swelling in rats (400 mg/kg, ip), and it could also significantly inhibit the proliferation of granulation tissue in mice (800 mg/kg, ip). These findings indicated that Wu-Ling-Zhi has obvious anti-inflammatory effect. Furthermore, the ethyl acetate extract of Wu-Ling-Zhi was also found to be able to protect gastric mucosa and prevent experimental gastric ulcer by inhibiting gastric acid secretion \[[@CR26]\]. It was reported that the aqueous extract of Wu-Ling-Zhi could significantly prolong the survival time of mice with incomplete cerebral ischemia, reduce the brain water content, brain index and malondialdehyde (MDA) level, and increase superoxide dismutase (SOD) activity in rats, indicating that Wu-Ling-Zhi has good protective effect against cerebral ischemia \[[@CR27]\]. Moreover, the aqueous extract of Wu-Ling-Zhi could down-regulate the expression of intercellular adhesion molecule-1 in experimental atherosclerotic rats and reduce the degree of vascular endothelial lesions, which may account for the anti-arteriosclerosis inflammatory effects of Wu-Ling-Zhi \[[@CR28]\]. Currently, several compounds isolated from Wu-Ling-Zhi, such as 3-*O*-α-[l]{.smallcaps}-(2″*E*,4″*E*-di-*p*-coumaroyl)-rhamnoside, bis(7-hydroxyheptyl) decanedioate and bis(7-hydroxyheptyl) octanedioate, were found to have significant antithrombin activity \[[@CR14], [@CR17]\]. Besides, a recent study showed that Wu-Ling-Zhi could trigger caspase dependent apoptosis in breast cancer cells (MCF-7 cells) \[[@CR29]\].Table 3Pharmacological activities and mechanisms of some compounds isolated from Wu-Ling-Zhi and Hei-Bing-PianNameClassificationCompoundPharmacological activityEffect and mechanismRefs.Wu-Ling-ZhiTerpenoidsTormentic acidAntiangiogenic activityControlling abnormal proliferation and cell death resistance of vascular smooth muscle cell without affecting the normal vasculature\[[@CR68]\]Euscaphic acidAnti-inflammatory activityInhibition of LPS-induced inflammatory responses by interference with the clustering of TRAF6 with IRAK1 and TAK1\[[@CR69]\]Jacoumaric acidCytotoxic activitySignificant cytotoxicity effect against P-388 lymphocytic leukemia cell\[[@CR10]\]3-*O*-*cis*-*p*-coumaroy ltormentic acid2α-hydroxy ursolic acidAnticancer activityInhibition of cell proliferation and induction of apoptosis by regulating the p38/MAPK signal transduction pathway\[[@CR70]\]Pomolic acidAnti-inflammatory and apoptotic activitiesInhibiting inflammatory response by regulating human neutrophil function\[[@CR71]\]Ursolic acidAnticancer and anti-inflammatory activitiesInhibition of tumor growth and induction of apoptosis by modulating the MAPK/ERK and PI3 K/AKT/mTOR pathways; Inhibiting inflammation by suppression of NF-κB, AP-1 and NF-AT activity\[[@CR72]\]Maslinic acidAnticancer activityIt can significantly suppress pancreatic tumor growth, induce tumor apoptosis and inhibit NF-κB-regulated anti-apoptotic gene expression\[[@CR73]\]Wulingzhic acidAnticoagulative activityProlongation of thrombin time and inhibiting platelet aggregation\[[@CR13], [@CR19]\]Wulingzhic acid AWulingzhic acid BTrogopteroids A--GCytotoxic activityCytotoxicity effect against seven human tumor cells, such as HepG2, HL-60 and U937\[[@CR12]\]8β-hydroxy-3-oxopimara-15-eneAkhdardiolIsopimara-7(8),15-dien-3β-olIsopimara-8,15-dien-3β-olSempervirolMacrophynin EFerruginolGastroprotective activityIncreasing PGs content, protecting cells from lipid peroxidation and improving gastric ulcer healing\[[@CR74]\]EpifriedelanolAntioxidant and anti-inflammatory activitiesAttenuating the secondary injury in TBI rats by reducing serum cytokine levels and oxidative stress\[[@CR75]\]FlavonoidsHinokiflavoneAnti-inflammatory activityInhibiting the LPS-induced expression of iNOS and COX-2 and the activation of NF-κB and ERK-1/2\[[@CR76]\]AmentoflavoneAnti-diabetic activityRegulating glucose and lipid metabolism via anti-oxidant effects and activating the PI3K/Akt pathway\[[@CR77]\]Kaempferol-3-*O*-α-[l]{.smallcaps}-(2″*E*,4″*E*-di-*p*-coumaroyl)-rhamnosideAnticoagulative activitySignificant prolongation of thrombin time\[[@CR14]\]Kaempferol-3-*O*-α-[l]{.smallcaps}-(3″*E*,4″*E*-di-*p*-coumaroyl)-rhamnosideKaempferol-3-*O*-α-[l]{.smallcaps}-(4″*E*-*p*-coumaroyl)-rhamnosideAfzelinAntioxidant and anti-inflammatory activitiesInhibiting particulate matter-induced proinflammatory cytokine mRNA expression and protein secretion; Inhibiting intracellular ROS generation, and p38 mitogen-activated protein kinase and transcription factor activator protein-1 component c-Fos and c-Jun activation\[[@CR78]\]QuercitrinGastroprotective and antioxidant activitiesInhibition of oxidative stress, regulation of mitochondrial dysfunction, and initiation of antioxidant defense\[[@CR79]\]LignansTrogopterins A, B, and CCytotoxic activityCytotoxicity effect against different types of cancer cells, such as HL-60, HeLa, and MCF-7\[[@CR16]\]SteroidsDaucosterolAnti-colitis activityInhibiting dextran sulfate sodium (DSS)-induced colitis in mice by relieving inflammation and restoring the number of Treg cells\[[@CR80]\]β-sitosterolAnti-inflammatory activityInhibition of intracellular adhesion molecule 1 expression in TNF-α-stimulated HAEC as well as the binding of U937 cells to TNF-α-stimulated HAEC and attenuating the phosphorylation of nuclear factor-kB p65\[[@CR81]\]Cholic acidAnti-inflammatory activitySignificantly decreasing the content of PGE~2~ in inflammatory tissue\[[@CR82]\]Deoxycholic acidAnti-inflammatory activityInhibiting fMLP-induced monocyte and neutrophil chemotaxis and calcium mobilization\[[@CR83]\]Ursodeoxycholic acidAnti-inflammatory activityAmeliorating experimental colonic inflammation in rats at a high dose (50 mg/kg day) by enhancing mucosal defense\[[@CR84]\]Taurocholic acidAnti-inflammatory activityInhibiting the production of inflammatory mediators, such as NO, PGE~2~ and histamine\[[@CR85]\]Others*Bis*(7-hydroxyheptyl)decanedioateAnticoagulative activitySignificant prolongation of thrombin time\[[@CR17]\]*Bis*(7-hydroxyheptyl)octanedioateProtocatechuic acidAnti-inflammatory and analgesic activitiesSignificantly decreasing LPO, NO levels and increasing SOD, catalase and GSH levels; significantly increasing the hot pain threshold of experimental mice, and obviously decreasing the frequency of writhing body response\[[@CR91]\]Hei-Bing-PianSteroidsCholic acidAnti-inflammatory activitySignificantly decreasing the content of PGE~2~ in inflammatory tissue\[[@CR82]\]Taurocholic acidAnti-inflammatory activityInhibiting the production of inflammatory mediators, such as NO, PGE~2,~ and histamine\[[@CR85]\] Table 4Basic pharmacological data of commonly used fecal medicines mentioned in the articleNameType of extractAnimal or cellNDoseMinimal active concentrationIn vitro/In vivoPositive controlNegative controlDurationEffect and mechanismRefs.Wu-Ling-ZhiEthyl acetate extractRats815--120 mg/kg15 mg/kgIn vivoRanitidineNormal saline12 hInhibiting gastric acid secretion and protecting gastric mucosa\[[@CR86]\]Ethyl acetate extractRats10200--800 mg/kg400 mg/kgIn vivoAspirinNormal saline30 minInhibiting the synthesis or release of prostaglandin E (PGE)\[[@CR25]\]Ethanol extractMCF-7 cells525--400 μg/ml100 μg/mlIn vitro--DMSO24 hIncreasing the expression levels of Caspase 3 and Caspase 9\[[@CR29]\]Ethyl acetate extractRabbits30.62--1.04 mg/ml0.78 mg/mlIn vitroAspirinDMSO; 60% ethanol; PBS10 minSignificant prolongation of thrombin time\[[@CR87]\]Water extractRabbits530.8--616 μg/kg56,225 μg/kgIn vitro--Normal saline10--15 minSignificant increase of cAMP level in platelets\[[@CR88]\]Water extractRats7200--300 mg/kg200 mg/kgIn vivo-Normal saline20 minWater extractRats820--60 mg/kg60 mg/kgIn vivoLigustrazineNormal saline7 daysSignificant reduction of MDA and IL1-β levels; increasing SOD activity\[[@CR89]\]Water extractMice and rats105--10 g/kg5 g/kgIn vivoNimodipineNormal saline--Reducing the brain water content, brain index and MDA level, and increasing SOD activity\[[@CR27]\]Water extractRats152.5--10 g/kg2.5 g/kgIn vivo--Normal saline6 weekDown-regulation of the expression of intercellular adhesion molecule-1 in experimental atherosclerotic rats and reducing the degree of vascular endothelial lesions\[[@CR28]\]Hei-Bing-PianAqueous solutionRats80.5--2 g/kg0.5 g/kgIn vivoHydrocortisone acetate--10 daysIncreasing the expression of SOD and GSH, and reducing the expression of NO and MDA\[[@CR40]\]Aqueous solutionRabbits20.01--0.2 g/ml--In vitro--Tyrode's solution30 minRegulating the cholinergic M receptor and histamine receptor\[[@CR41]\]Rats60.05--0.1 g/kg--In vivo----30 minAqueous solutionRats81--5 g/kg5 g/kgIn vivoDomperidoneNormal saline30 minAccelerating the rate of gastric emptying, promoting gastrointestinal peristalsis and protecting gastric mucosa\[[@CR42]\]Mice101--5 g/kg5 g/kgIn vivoDomperidoneNormal saline30 minRats81--5 g/kg5 g/kgIn vivoKuai-Wei tabletsNormal saline15 days0.5% CMC-Na solutionRats204--12 g/kg--In vivo--Distilled water12 wNo toxicity was observed after long-term administration\[[@CR43]\]

Fecal medicines used in other traditional ethnic medicine systems in China {#Sec6}
--------------------------------------------------------------------------

In addition to the TCM system, there are other traditional medical systems in China, such as Tibetan, Mongolian, Uygur, Tujia, Kazak, Yao, Korean, and Dai ethnic medicines. These ethnic medical systems have their own unique theories in the use of natural medicines. Therefore, it is also important to collect information about fecal medicines from these ethnic medical systems.

Traditional Tibetan medicine (TTM) is a representative ethnic medicine in China, and it has a unique fundamental theory, namely three elements theory consisting of "*rLung*", "*mKhris*-*pa*" and "*Badkan*" \[[@CR30]\]. In TTM system, the use of fecal medicines has a long history. The earliest Tibetan medicine monograph that recorded fecal medicines is "*The Four Medical Tantras*" \[[@CR2]\]. Later, in the seventeenth century, famous "*Tibetan Medical Thangka of The Four Medical Tantras*" \[[@CR31]\] was published by Sde-srid-sangs-rgyas-rgya-mtsho, which vividly depicted some commonly used fecal medicines in the form of wall chart (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3The Tibetan medical Thangka of "*The Four Medical Tantras*" vividly depicts some feces medicines and their origin animals (**a** *Tetrao urogallus*; **b** *Gallus gallus domesticus*; **c** *Pica pica*; **d** *Columba livia domestica*; **e** *Passer montanus*; **f** *Aegypius monachus*; **g** *Equus caballus orientalis*; **h** *Equus asinus*; **i** *Homo sapiens*; **j** *Bos taurus domesticus*; **k** *Canis lupus*; **l** *Sus scrofa*; **m** *Canis lupus familiaris*; **n** *Rattus rattus*; **o** *Lepus oiostolus*)

In this study, we found that the feces of 41 animals were used as medicines for the treatment of various diseases in 13 ethnic medical systems. More information on these medicines is provided in Table [2](#Tab2){ref-type="table"}. Among them, the dry feces of *Gypaetus barbatus* or *Aegypius monachus* and the processed product of the feces of *Sus scrofa* are representative fecal medicines in Chinese ethnic medicine systems. Their traditional uses, chemical constituents and pharmacological activities have been described in detail in the following sections.

### The dry feces of *Gypaetus barbatus* or *Aegypius monachus* (Jiu-Fen in Chinese) {#Sec7}

The dry feces of *G. barbatus* or *A. monachus*, known as Jiu-Fen in Chinese, is a commonly used Tibetan medicine (Fig. [1](#Fig1){ref-type="fig"}d). It has the functions of strengthening stomach and promoting digestion. Jiu-Fen is used in the traditional Tibetan system of medicine for the treatment of dyspepsia, gastrointestinal dysfunction, gastric ulcer, and intestinal cancer in the past few decades \[[@CR4], [@CR6]\]. In addition, the "*Jing Zhu Materia Medica*" recorded that Jiu-Fen can be used to treat mental illness \[[@CR4]\]. Nowadays, Jiu-Fen is frequently used in the clinical practice of TTM by combining other herbs. According to our statistics, there are 32 preparations containing Jiu-Fen in some monographs and drug standards of Tibetan medicine \[[@CR6], [@CR32]--[@CR35]\]. The representative prescriptions include "Shi-Wei-Jiu-Fen Powder", "Er-Shi-Jiu-Wei-Neng-Xiao Powder" and "Jian-Hua-Mu-Xiang Pills" (Table [5](#Tab5){ref-type="table"}). The "*Tibetan Medicine Standards*" recorded that "Shi-Wei-Jiu-Fen Powder" can strengthen stomach and promote digestion \[[@CR6]\]. Consequently, it is usually used to treat gastrointestinal diseases such as dyspepsia.Table 5Representative prescriptions containing fecal medicines recorded in official drug standardsFecal medicineTraditional medical systemThe number of preparationsThe name of prescriptionsDrug standardRefs.Wu-Ling-ZhiTCM15Shi-Xiang-Zhi-Tong Pills; Tong-Jing Pills; Shao-Fu-Zhu-Yu Pills; Xiao-Jin Pills; Shi-Er-Wei-Yi-Shou Powder; Er-Shi-Wu-Wei-Song-Shi Pills; Qi-Wei-Tie-Xie Pills; Jiu-Qi-Niao-Tong Pills; Ping-Xiao Pills; Hua-Zheng-Hui-Sheng Tablets; Feng-Liao-Xing-Feng-Shi-Die-Da Wine; Yang-He-Jie-Ning Plaster; Tong-Jing-Bao Granules; Jie-Bai Pills; Bing-Lang-Si-Xiao PillsChinese Pharmacopoeia, 2015ed\[[@CR7]\]Can-ShaTCM2Shu-Jing-Huo-Luo Wine; Feng-Liao-Xing-Feng-Shi-Die-Da WineChinese Pharmacopoeia, 2015ed\[[@CR7]\]Ye-Ming-ShaTCM1Huang-Lian-Yang-Gan PillsChinese Pharmacopoeia, 2015ed\[[@CR7]\]Jiu-FenTibetan EM12Shi-Wei-Jiu-Fen Powder; Er-Shi-Jiu-Wei-Neng-Xiao Powder; Jian-Hua-Mu-Xiang Pills; Shi-San-Wei-Mu-Xiang Pills; Shi-San-Wei-Shi-Liu Pills; De-Ma-Shi-San-Wei-Shi-Liu Pills; Shi-San-Wei-Mu-Xiang Powder; Jia-Wei-Bai-Yao Pills; Qu-Hui Pills; Qu-Han-Quan-Lü Powder; Song-Shi-Da-Peng Pills; Shi-San-Wei-Qing-Lan PillsDrug Standards of Tibetan Medicines; Tibetan Medicine Standards\[[@CR6], [@CR35]\]Hei-Bing-PianTibetan EM14Shi-Wei-Hei-Bing-Pian Powder; Shi-Yi-Wei-Jin-Se Pills; Shi-Wu-Wei-Zhi-Xie-Mu Powder; Gan-Lu-Ling Pills; Er-shi-Si-Wei-A-Wei Powder; Shi-Yi-Wei-He-Zi Powder; Shi-San-Wei-Di-Da Powder; Niu-Huang-Qing-Peng Pills; He-Zi-Neng-Xiao Pills; He-Zi-Qing Peng-Pills; Jin-Se-Di-Da Pills; Er-shi-Jiu-Wei-Qiang-Huo Powder; Shi-San-Wei-Shu-Tu-Qing-Peng Powder; Shi-Yi-Wei-Jin-Se PowderDrug Standards of Tibetan Medicines; Tibetan Medicine Standards\[[@CR6], [@CR35]\]Wu-Ling-ZhiMongolian EM23Yun-Xiang-Shi-Wu-Wei Pills; Zhi-Li-Shi-Wei-Hei Pills; Niu-Huang-Shi-San-Wei Pills; Wen-Guan-Mu-Shi-Wei Powder; Ji-Xiang-An-Kun Pills; Li-Gan-He-Wei Pills; He-Zi-Wu-Wei Capsules; Bu-Sheng-Jian-Wei-Er-Shi-Yi Pills; Feng-Xiang-Zhi-Shi-Wei Pills; Cao-Guo-Jian-Pi Pills; Ha-Dun-Hai-Lu-Mu-Le-Shi-San-Wei Pills; Ha-Dun-Hai-Lu-Mu-Le-Jiu-Wei Pills; Jian-Wei-Shi-Wei Pills; Jian-Pi-Wu-Wei-Pills; Qing-Gan-Qi-Wei Powder; Tiao-Yuan-Da-Bu-Er-Shi-Wu-Wei Decoction; Ju-Hua-Qi-Wei Capsules; Qing-Gan-Jiu-Wei Powder; Qing-Shen-Re-Shi-Wei Powder; Qing-Wen-Shi-Er-Wei Pills; Qing-Wen-Zhi-Tong-Shi-Si-Wei Pills; Qing-Wen -Li-Dan-Shi-San-Wei Pills; Xi-Hong-Hua-Shi-Liu-Wei PowderDrug Standards of Mongolian Medicines\[[@CR90]\]Hei-Bing-PianMongolian EM7Zhi-Li-Shi-Wu-Wei Pills; He-Zi-Wu-Wei Capsules; A-Na-Ri-Ba-Wei Powder; Ha-Ri-Shi-Er-Wei Powder; Ha-Dun-Hai-Lu-Mu-Le-Shi-San-Wei Pills; Qing-Gan-Er-Shi-Qi-Wei Pills; Shi-Wei-Hei-Bing-Pian PowderDrug Standards of Mongolian Medicines\[[@CR90]\]Ye-Ming-ShaMongolian EM1Ming-Mu-Shi-Liu PillsDrug Standards of Mongolian Medicines\[[@CR90]\]Long-Xian-XiangUygur EM1Yi-Mu-Sa-Ke TabletsDrug Standards of Uygur Medicines\[[@CR92]\]

The use of Jiu-Fen in the traditional Tibetan system of medicine has a long history, but modern research on the chemical composition, quality control and pharmacodynamic evaluation of Jiu-Fen has not yet been carried out. Therefore, further studies are needed to prove its medicinal values in gastrointestinal diseases treatment, identify active compounds and elucidate the underlying mechanisms with the help of modern chemistry and pharmacology methods.

### The processed product of the feces of *Sus scrofa* (Hei-Bing-Pian in Chinese) {#Sec8}

The processed product of the feces of *Sus scrofa* (wild boar), known as Hei-Bing-Pian (Chinese name), is a widely used Tibetan and Mongolian medicine in China (Fig. [1](#Fig1){ref-type="fig"}e). Its processing method was recorded in the "*Chinese Materia Medica for Tibetan Medicine*": firstly, the dry feces of *Sus scrofa* is put into a ceramic jar, and yellow mud (adding a small amount of salt) is used to seal the ceramic jar. Secondly, the ceramic jar is calcined with fire until it turns gray outside. Then, the black matter is taken out from the ceramic jar, which is Hei-Bing-Pian \[[@CR36]\]. In traditional Tibetan system of medicine, Hei-Bing-Pian is described as pungent in flavor and hot in nature. It is commonly used for the treatment of dyspepsia, gallbladder diseases, stomachache, and plague \[[@CR6]\]. According to our statistics, there are 14 Tibetan medicine preparations containing Hei-Bing-Pian in official drug standards. The representative prescriptions include "Shi-Wei-Hei-Bing-Pian Powder", "Shi-Yi-Wei-Jin-Se Pills" and "Shi-Wu-Wei-Zhi-Xie-Mu Powder" (Table [5](#Tab5){ref-type="table"}). The "*Drug Standards of Tibetan Medicines*" recorded that "Shi-Wei-Hei-Bing-Pian Pills" is usually used to treat stomach and gallbladder diseases, such as dyspepsia, anorexia, jaundice, gallstones and nausea \[[@CR35]\].

It has been reported that Hei-Bing-Pian contains a variety of inorganic elements, such as Fe, Ca, Zn, K, Cu, Mn, Co, Ti, and Mg. At present, the contents of these elements in Hei-Bing-Pian have been determined by using atomic absorption spectrometry or spectrophotometry \[[@CR37], [@CR38]\]. The elements with high levels are Ca (18,570 μg/g), K (11,625 μg/g), Mg (9975 μg/g), and Fe (7800 μg/g). Furthermore, two bile acids (i.e., cholic acid and taurocholic acid) were detected and quantified in Hei-Bing-Pian by using ultra high-performance liquid chromatography-mass spectrometry method \[[@CR21]\]. Besides, Chang et al. \[[@CR39]\] developed a spectrophotometric method to determine the absorption force of Hei-Bing-Pian on tartrazine, and used this adsorption force as an indicator to control the quality of Hei-Bing-Pian.

Modern pharmacological study has demonstrated that Hei-Bing-Pian can prevent mucosal damage caused by experimental colitis in rats. Compared with the model group, the high and low doses of Hei-Bing-Pian can significantly reduce the damage of colonic mucosa congestion, hyperplasia and ulcer (*p* \< 0.05), and significantly increase the levels of superoxide dismutase (SOD) and glutathione (GSH) \[[@CR40]\]. Cai et al. \[[@CR41]\] reported the effect of Hei-Bing-Pian on the intestinal smooth muscle function of animals. It was found that Hei-Bing-Pian had no obvious effect on normal isolated ileum, and could not antagonize the inhibitory effect of atropine, adrenaline and promethazine on isolated ileum smooth muscle. However, it could significantly inhibit histamine-induced ileal smooth muscle excitation, and the inhibition rate was 25%. Moreover, in vivo studies showed that Hei-Bing-Pian could inhibit the contraction effect of pilocarpine on ileal smooth muscle. These results indicate that the effect of Hei-Bing-Pian on intestinal smooth muscle is related to the cholinergic M receptor and histamine receptor. Bai et al. \[[@CR42]\] found that Hei-Bing-Pian could significantly accelerate gastric emptying in rats and promote the propulsive speed of activated carbon in the small intestine of mice. Moreover, the high dose of Hei-Bing-Pian could significantly promote the healing of chronic gastritis caused by acetic acid, and had obvious protective effect on gastric mucosal injury induced by cold stress. Besides, in order to make better use of Hei-Bing-Pian, its long-term toxic effects have been studied by Li et al. The results showed that, after 12 weeks of administration of Hei-Bing-Pian, there were no significant changes in body weight, blood biochemical parameters, histopathology, and several organ indexes (e.g., heart, liver, spleen, kidney, and thymus) in rats, compared with the control group, which indicated that Hei-Bing-Pian has no potential toxicity \[[@CR43]\]. The basic pharmacological data of Hei-Bing-Pian and its ingredients are shown in Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}.

Similarities and differences of fecal medicines related to treated diseases in Chinese traditional medical systems {#Sec9}
------------------------------------------------------------------------------------------------------------------

Every traditional medical system in China has its own unique theory or medication experience. Therefore, the same fecal medicines are used in different medical systems, and their therapeutic uses may be different. A detailed comparison of these differences would help researchers and traditional medical practitioners to better understand the indications of fecal medicines and promote their development and utilization. In this study, we compared the similarities and differences of therapeutic uses of Wu-Ling-Zhi and Hei-Bing-Pian in different traditional medical systems, including TCM, Tibetan EM, Korean EM, Dai EM, Yao EM, Tujia EM, Nu EM, and Mongolian EM. Additional details are provided in Table [6](#Tab6){ref-type="table"}. The results indicate that Wu-Ling-Zhi is commonly used to treat amenorrhea and dysmenorrhea in most traditional medical systems. However, its therapeutic uses also have some obvious differences in different medical systems. For example, in the Tibetan EM, Wu-Ling-Zhi can be used to treat stomachache, whereas in the Mongolian EM, it is mainly used to treat diarrhea, gout and itching. Moreover, Wu-Ling-Zhi can treat cold, whooping cough and fever in the Nu EM. Hei-Bing-Pian has the same therapeutic use in TCM and Tibetan EM systems. It is widely used in both systems to treat dyspepsia, biliary diseases, plague and distending pain in the stomach. There is no difference in the therapeutic use of Hei-Bing-Pian in the two medical systems.Table 6Similarities and differences of fecal medicines related to treated diseases in Chinese traditional medical systemsNameTraditional medical systemOriginal speciesIdentical indicationsDifferent indicationsRefs.Wu-Ling-ZhiTCM*Trogopterus xanthipes* Milne-EdwardsAmenorrhea and dysmenorrheaStabbing pain in the chest and abdomen, swelling and aching due to traumatic injury, and snake bites (external use)\[[@CR5], [@CR8], [@CR52]\]Tibetan EMStomachache\[[@CR59], [@CR60]\]Korean EMStabbing pain in chest and abdomen\[[@CR60]\]Dai EMSnake bites (external use)\[[@CR60]\]Yao EMEpilepsy\[[@CR63]\]Tujia EMSwelling and aching due to traumatic injury, and snake bites (external use)\[[@CR60]\]Nu EM--Cold, whooping cough and fever\[[@CR60]\]Mongolian EM--Diarrhea, gout and itching\[[@CR62]\]Hei-Bing-PianTibetan EM*Sus scrofa* L.Dyspepsia, biliary diseases, plague and distending pain in the stomach--\[[@CR6], [@CR36], [@CR59]\]Mongolian EM

Conclusion and future perspectives {#Sec10}
==================================

Chinese traditional medicine is an important part of the world's medical system. In long-term clinical practice, ancient Chinese doctors have accumulated invaluable experience in the use of fecal medicines. As shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, some fecal medicines have been found to be effective in treating amenorrhea, dysmenorrhea dyspepsia, diarrhea, fever, and stomachache. These traditional medication knowledge are valuable assets. Currently, some fecal medicines (e.g., Wu-Ling-Zhi, Jiu-Fen and Hei-Bing-Pian) are still used in clinical practice. A total of 76 preparations containing fecal medicines were recorded in the latest official drug standards (Table [5](#Tab5){ref-type="table"}). Extensive clinical application demonstrates the role and value of fecal medicines in Chinese medical systems. Moreover, Wu-Ling-Zhi extracts and its chemical constituents have been proved to possess a wide spectrum of biological activities, such as anti-inflammatory, anticoagulative and antioxidant effects (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). Some possible molecular mechanisms have also been revealed. The results of these modern pharmacological studies provide some evidences to prove the scientific nature of fecal medicines. However, most fecal medicines still lack experimental evidences. For example, Jiu-Fen is a commonly used Tibetan medicine. However, so far, no biological activities or active ingredients have been reported for this drug. Therefore, in order to better develop and utilize these fecal medicines, more in vivo pharmacological studies and even clinical evaluations should be performed to prove their scientific and medicinal value.

Fortunately, an in-depth study of gut microbiota has provided an opportunity to interpret the scientific connotation of some traditional fecal medicines, such as the yellow soup. This soup is a fresh fecal suspension of *Homo sapiens* commonly used to treat food poisoning, severe diarrhea, heat toxins, and unconsciousness due to high fever. Zhang et al. \[[@CR44], [@CR45]\] believe that the efficacy of yellow soup is mainly caused by the gut microbiota from fresh fecal water, and its principle for treating diseases is similar to the fecal microbiota transplantation method of modern medicine. Therefore, reconstructing the gut microbiota of patients may be the mechanism of action of fresh fecal medicines for treating diseases.

However, most fecal medicines are derived from dry feces (e.g., Wu-Ling-Zhi) or processed products (e.g., Hei-Bing-Pian). During drying and processing, these fecal medicines lose the living microbiota. Therefore, their mechanisms for treating diseases may be different from fresh feces. Feces are intestinal excretions of humans or animals. The chemical constituents in feces are mainly derived from the host or dietary metabolites. These metabolites may be the key active constituents of fecal medicinal materials. For example, the terpenoids, flavonoids and lignans contained in Wu-Ling-Zhi are closely related to the foods eaten by *Trogopterus xanthipes* (e.g., *Platycladus orientalis* leaves, *Pinus tabulaeformis* bark, and peach kernels). These diet-derived metabolites may be the pharmacologically active ingredients of Wu-Ling-Zhi. Moreover, some bile acids (e.g., deoxycholic acid, lithocholic acid and taurocholic acid) have been found in Wu-Ling-Zhi and Hei-Bing-Pian \[[@CR21]\]. These bile acids are the final metabolites of cholesterol under the common metabolism of liver and gut microbiota. Bile acids are endocrine-signaling molecules that regulate metabolic processes, including glucose, lipid and energy homeostasis, by regulating gut microbiota or activating bile acid receptors, such as the farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 \[[@CR46]--[@CR48]\]. Distrutti et al. \[[@CR49]\] reported that bile acids-activated receptors are targets for maintaining intestinal integrity. Gadaleta et al. \[[@CR50]\] found that FXR activation could prevent chemically induced intestinal inflammation with an improvement of colitis symptoms and inhibition of epithelial permeability. In addition, bile acids can also regulate cardiovascular functions via receptor-dependent and -independent mechanisms \[[@CR51]\]. These findings provide a rationale to explore the mechanisms of Hei-Bing-Pian and Wu-Ling-Zhi in the treatment of gastrointestinal and cardiovascular diseases, respectively.

With the continuous development of science and technology, some unique but sometimes incomprehensible drugs in traditional medical systems will gradually be recognized. In this study, we provide the first comprehensive data compilation of fecal medicines used in Chinese traditional medical systems. The information recorded in ancient monographs and drug standards, such as original species, traditional uses and indications, can provide a good reference for the development and utilization of fecal medicines. In view of the current research status of fecal medicines, future research may focus on the following aspects: (1) applying multidisciplinary methods to further prove their effectiveness and medicinal value, (2) revealing their active ingredients associated with clinical efficacy using phytochemical and pharmacodynamic methods, and (3) elucidating the mechanisms of action of fecal medicines based on gut microbiota or receptor-mediated signaling pathways.

TCM

:   traditional Chinese medicine

TTM

:   traditional Tibetan medicine

EM

:   ethnic medicine
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